13.07.2018 • News

LyondellBasell-Braskem “Done Deal” by October?

LyondellBasell-Braskem “Done Deal” by October?
LyondellBasell-Braskem “Done Deal” by October?

Brazilian conglomerate Odebrecht is poised to agree on the sale of its controlling stake in compatriot petrochemical producer Braskem to LyondellBasell by mid-October, according to a report by Brazilian financial newspaper Valor Econômico.

By that time, the paper said, Braskem’s other major shareholder, oil giant Petrobras, will decide whether to include its own stake. This would allow the transaction to be wrapped up as one and submitted to regulators.

Odebrecht currently owns 50.1% of Braskem's voting capital, while Petrobas holds 47%. LyondellBasell and Odebrecht confirmed last month that they were in exclusive talks for the Dutch-headquartered, US-managed chemical producer to acquire control of Braskem in a cash-and-shares deal.

Valor calculates that Odebrecht’s stake could be worth more than 21 billion Brazilian reais ($5.4 billion), which would place Braskem’s value at about 55 billion reais ($14.3 billion).

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read